Sponsor or institution

Clinical trials and research at Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

• 46Clinical trials
• 1New in 30 days
• 1Country

Newest trials

All recruiting trials (46)

• Sonrotoclax plus azacitidine in high-risk MDS with increased blasts-2

  This study tests whether adding sonrotoclax to azacitidine can help people with newly diagnosed high-risk MDS with increased blasts-2 see better disease control and tolerable safety.

  Recruiting Phase 1/2 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality and 5 other locations · NCT07885397

• Acupuncture to Improve Sleep and Reduce Pain After Lung Cancer Surgery (VATS)

  This trial tests whether acupuncture given around surgery can improve sleep and lessen chronic pain for adults undergoing video-assisted thoracoscopic lung cancer removal.

  Recruiting at 2 sites Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality and 1 other locations · NCT07662733

• STN-targeted non-invasive brain stimulation for Parkinson’s symptoms

  A non-invasive procedure called tTIS is tested in people with Parkinson’s to see if it helps motor and non-motor symptoms.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT07625540

• Nimotuzumab plus Immunotherapy and Chemotherapy before surgery for locally advanced head and neck cancer

  This phase 2 trial tests whether adding nimotuzumab to immunotherapy and chemotherapy before surgery helps people with locally advanced head and neck squamous cell carcinoma.

  Recruiting Phase 2 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT07601737

• Risk predictor for new urinary incontinence after prolapse surgery

  This study tests a model to predict which women might develop new stress urinary incontinence after pelvic organ prolapse repair.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT07601282

• See if EUS-SWQ can accurately detect and grade liver fibrosis in adults with chronic liver disease

  This study tests whether the endoscopic ultrasound shear wave quantification (EUS-SWQ) can match liver biopsy results in adults with chronic liver disease to diagnose and stage fibrosis, and whether it offers safety and measurement advantages over FibroScan.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT07588854

• Low-dose ATG/PTCy plus ivarmacitinib to prevent acute GVHD after haploidentical PBSC transplant from parous female donors

  This tests whether adding the oral JAK1 inhibitor ivarmacitinib to low-dose ATG and post‑transplant cyclophosphamide can prevent acute GVHD in adults receiving haploidentical peripheral blood stem cell transplants from parous female donors.

  Recruiting Phase 2 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT07570745

• Treatment options for peripheral T‑cell lymphoma after no response to first‑line therapy

  This project will try allogeneic stem cell transplant versus other salvage treatments for adults with peripheral T‑cell lymphoma who did not respond to first‑line chemotherapy.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT07470996

• Safety and tolerability of Ga-68/Lu-177 BRP-020063 in patients with advanced solid tumors

  This study tests whether Ga-68/Lu-177 BRP-020063 is safe and tolerable in adults with advanced metastatic solid tumors, including urothelial carcinoma, with a small group receiving a low therapeutic dose if imaging suggests uptake.

  Recruiting Early Phase 1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT07439120

• Adebrelimab for advanced small cell lung cancer in routine care

  This project will try adebrelimab, a PD-L1 blocker, in adults with extensive-stage small cell lung cancer to see how safe it is and how well it controls the disease in routine clinical care.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT07434518

• Golidocitinib versus placebo as maintenance treatment for PTCL patients in remission after first-line chemotherapy

  This trial tests whether taking golidocitinib every other day can help keep peripheral T‑cell lymphoma from coming back in adults who responded to first‑line chemotherapy but cannot have a stem cell transplant.

  Recruiting Phase 3 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT07414758

• Cidabenamine plus azacitidine to prevent post-transplant progression in high-risk peripheral T‑cell lymphoma

  This trial will test whether adding cidabenamine to azacitidine after allogeneic stem cell transplant can help prevent progression in adults with high‑risk peripheral T‑cell lymphoma.

  Recruiting Phase 2/3 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT07389616

• LX111 gene therapy for adults with diabetic macular edema.

  This treatment will try a single eye injection of LX111 gene therapy in adults with diabetic macular edema to see if it is safe and reduces retinal swelling and improves vision.

  Recruiting Early Phase 1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai and 1 other locations · NCT07362927

• Treatment choices after a complete response to first-line therapy for peripheral T‑cell lymphoma

  This study will test whether autologous stem cell transplant or observation leads to better outcomes for people with peripheral T‑cell lymphoma who are in complete response after first‑line chemotherapy.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT07353840

• Allogeneic versus Autologous Hematopoietic Stem Cell Transplant for Peripheral T‑Cell Lymphoma in Partial Response after First‑line Therapy

  This study will test whether allogeneic or autologous stem cell transplant works better and is safer for adults with peripheral T‑cell lymphoma who have a partial response after first‑line treatment.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT07253129

• Antibiotics versus no antibiotics for flexible ureteroscopy with a negative-pressure suction sheath

  This trial will test whether adults at low risk of infection having single-use flexible ureteroscopy with a negative-pressure suction sheath can safely skip the usual single-dose antibiotic before surgery.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT07246967

• 177Lu-CTR-FAPI treatment for advanced, metastatic pancreatic cancer

  This single-center, open-label study will try a radioligand called 177Lu-CTR-FAPI in people with advanced or metastatic pancreatic cancer (and other solid tumors) who have run out of standard treatment options.

  Recruiting Early Phase 1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT07229768

• AI app to monitor and support nutrition after pancreatic cancer surgery

  This will test whether an AI app that collects symptoms, photos, and patient-reported data can help detect nutritional risk and guide support for people after radical pancreatic cancer surgery.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT07167264

• Anti-EBV autologous TCR-T cell injection for relapsed or refractory EBV-positive lymphoma

  This trial will test whether injections of a patient's own anti-EBV TCR-T cells are safe and help adults (18–70) with relapsed or refractory EBV-positive lymphoma who have HLA-A11:01.

  Recruiting Early Phase 1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT07162012

• LX107 gene therapy for AIPL1-related retinal dystrophy

  This trial will try a single subretinal injection of LX107 gene therapy in people aged 4 and up with retinal dystrophy caused by two AIPL1 mutations to see if it improves vision and is safe.

  Recruiting Early Phase 1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT07063030

• LX111 gene therapy for neovascular (wet) age-related macular degeneration

  This will test a single eye injection of LX111 gene therapy in people 50 and older with active wet AMD to see if it is safe and helps maintain or improve vision.

  Recruiting Early Phase 1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT07053358

• Using bile analysis to diagnose unclear narrowings of the bile ducts

  This project will test whether analyzing bile with molecular 'omics' together with routine biliary brushings or biopsies can help find cancer in people with indeterminate biliary strictures.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, China · NCT07007832

• Radical lung tumor removal with lymph node dissection on both sides for N3 NSCLC

  This trial will test whether removing the lung tumor plus lymph nodes from both sides of the chest helps people with N3 non-small cell lung cancer live longer and reduce recurrence.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality and 1 other locations · NCT07003490

• Testing IGT001 for treating Retinitis Pigmentosa

  This study is testing a new treatment called IGT001 for people with retinitis pigmentosa to see if it can help improve their vision and how safe it is to use.

  Recruiting Phase 1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT06936787

• Donor-derived regulatory T cell infusion with interleukin-2 for refractory chronic GVHD

  This will try infusing donor-derived regulatory T cells together with low-dose recombinant interleukin-2 in adults with steroid-refractory or steroid-dependent chronic graft-versus-host disease.

  Recruiting Early Phase 1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT06920199

• New hormone therapy plus PSMA PET/CT–guided local treatment for metastatic hormone‑sensitive prostate cancer

  This trial will test whether adding local treatments guided by PSMA PET/CT to standard hormone therapy helps men with newly diagnosed metastatic hormone‑sensitive prostate cancer.

  Recruiting Phase 2 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06832774

• Characterizing infections in the eye using advanced sequencing techniques

  This study is trying to understand the different germs that cause eye infections by analyzing samples from people with conditions like pink eye and other serious infections.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06775808

• Preventing relapse in high-risk T-cell leukemia after stem cell transplant

  This study is testing if a new combination of medications can help prevent relapse in patients with high-risk T-cell leukemia after they have a stem cell transplant.

  Recruiting Phase 2 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT06686108

• Superpulse thulium fiber versus holmium:YAG laser for breaking kidney and upper ureter stones during ureteroscopy

  This trial tests whether the superpulse thulium fiber laser works better than the holmium:YAG laser for adults (18–70) having ureteroscopy to break 6–20 mm kidney or upper ureter stones.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06667557

• Treatment of advanced liver cancer with SN301A injection

  This study is testing if an injection called SN301A can help people with advanced liver cancer who haven’t had success with other treatments.

  Recruiting Early Phase 1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06652243

• Preventing relapse in high-risk MDS patients after transplantation

  This study is testing a new way to help very high-risk patients with myelodysplastic syndromes avoid relapse after a stem cell transplant.

  Recruiting Phase 2 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT06612944

• Combining BCL-2 inhibitors with HyperCVAD for treating T-lymphoblastic leukemia/lymphoma

  This study is testing whether combining BCL-2 inhibitors with the HyperCVAD treatment can help people who are newly diagnosed with T-lymphoblastic leukemia or lymphoma achieve better remission rates.

  Recruiting Phase 2 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT06598722

• Cadonilimab with S-1 or Capecitabine for advanced pancreatic cancer

  This study is testing if a new combination of Cadonilimab with either S-1 or capecitabine can help people with advanced pancreatic cancer who have already tried other treatments.

  Recruiting Phase 2 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06532617

• Combining adebelimab with chemotherapy for treating liver metastasis from pancreatic cancer

  This study is testing if combining a new drug called adebelimab with standard chemotherapy can help people with pancreatic cancer that has spread to the liver feel better and improve their treatment results.

  Recruiting Phase 2 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06531278

• Assessing Prognosis in Pancreatic Cancer Using Lewis Antigen and CA19-9 Tests

  This study is testing if combining Lewis antigen and CA19-9 tests can help doctors better understand the outlook for patients with pancreatic cancer.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06515587

• Combining Venetoclax, Azacitidine, and Homoharringtonine for treating high-risk Acute Myeloid Leukemia followed by stem cell transplant

  This study is testing a new combination of treatments for people with high-risk Acute Myeloid Leukemia to see if it helps them get better before they have a stem cell transplant.

  Recruiting Phase 2 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06483906

• Assessing Carotid Plaque Vulnerability to Predict Stroke and Heart Events

  This study is trying to see if special ultrasound tests can help predict the risk of strokes and heart problems in people with plaque in their carotid arteries.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06473272

• Treatment of pancreatic cancer with liver metastasis using combined therapies

  This study is testing a new treatment that combines heat therapy, immune therapy, and chemotherapy for people with pancreatic cancer that has spread to the liver to see if it works better than current options.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06307080

• Using CLL-1 CAR NK cells to treat relapsed or refractory acute myeloid leukemia

  This study is testing a new type of immune cell treatment for people with relapsed or hard-to-treat acute myeloid leukemia to see if it helps them feel better.

  Recruiting Phase 1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06307054

• Treatment of advanced liver cancer using QY-1-T immunotherapy

  This study is testing a new immunotherapy called QY-1-T to see if it can help people with advanced liver cancer related to hepatitis B who haven't had success with other treatments.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06251115

• Intensive conditioning for myeloid cancers with extramedullary involvement

  This study is testing a new treatment plan using specific medications before a stem cell transplant to see if it helps people with myeloid cancers that have spread beyond the bone marrow feel better and have better outcomes.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06111612

• Using rTMS to Delay Progression of Parkinson's Disease

  This study is testing whether a non-invasive treatment called rTMS can improve sleep and help people with Parkinson's Disease feel better and slow down their symptoms.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06002581

• Treatment using patients' own immune cells for advanced solid tumors

  This study is testing a new treatment that uses patients' own immune cells to see if it can help people with advanced solid tumors who haven't responded to other therapies.

  Recruiting Early Phase 1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality and 2 other locations · NCT05831033

• Evaluating LX103 treatment for X-linked Retinoschisis

  This study tests if a new eye treatment called LX103 can improve vision in boys and men with X-linked Retinoschisis.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT05814952

• Evaluating a new treatment for resectable gastric cancer

  This study is testing a new combination treatment for people with early-stage gastric cancer to see if it helps shrink tumors before surgery.

  Recruiting Phase 2 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT05536102

• Krill oil to slow progression of early and intermediate dry age-related macular degeneration

  This trial will test whether taking four krill oil capsules daily for three months can slow progression in adults with early or intermediate dry age-related macular degeneration.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT05465252

Quick answers

How many clinical trials run by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine are recruiting right now?

46, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 10, Early Phase 1: 9, Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →